HIF1A and non-small cell lung carcinoma: For 41 cases receiving a second biopsy after gaining EGFR-TKIs acquired resistance in 30 months, the expression level of HIF-1α after acquired resistance in NSCLC tissue was higher than that before receiving EGFR-TKIs treatment (P = 0.000, Table 3).